Neurobiological Tech (NTII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII)

NTII 0.0001000

0.0%

Jan 29 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BRAVEHEART who wrote (719)	11/18/1999 3:07:00 PM
From: JMarcus	Read Replies (1) of 1494

Do you think the anticipated good news is completely built into the current stock price, or might we see a spike when the neuropathic pain trial results are announced sometime next month? I'm looking for a spike. Anyone who reads the news (if it turns out to be as good as expected), considers the size of the diabetic neuropathy market, and then factors in the tiny market cap of the stock ought to consider this a very attractive investment at under $10. Marc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next